Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
6,725,971
-
Shares change
-
-1,474,706
-
Total reported value, excl. options
-
$18,154,786
-
Value change
-
-$5,363,149
-
Number of buys
-
13
-
Number of sells
-
-16
-
Price
-
$2.69
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q2 2015
36 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q2 2015.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,725,971 shares
.
Largest 10 shareholders include Versant Venture Management, LLC (1,048,601 shares), ADAGE CAPITAL PARTNERS GP LLC (1,000,000 shares), JENNISON ASSOCIATES LLC (858,786 shares), Lombard Odier Asset Management (USA) Corp (742,126 shares), Point72 Asset Management, L.P. (585,288 shares), Visium Asset Management, LP (550,948 shares), EverPoint Asset Management, LLC (468,099 shares), VANGUARD GROUP INC (332,307 shares), Iguana Healthcare Management, LLC (240,000 shares), and ALLIANCEBERNSTEIN L.P. (234,974 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.